E-ISSN 2602-3164

Volume: 8 Issue: 1 - 2024

Does Haematological Toxicity Increase with the Use of Lipophilic Chemotherapeutic Agents in Obese Breast Cancer Patients?
Duygu Bayir Garbioglu
doi: 10.14744/ejmi.2023.59404   Pages  1 -  7 
(Viewed: 453 / Downloaded: 578)

Prognostic Significance of C-Reactive Protein and Neutrophil- Lymphocyte Ratio in Lung Adenocarcinoma Patients
Akin Ozturk, Ozlem Oruc, Merve Hormet Igde, Ozgur Bilgin Topcuoglu, Murat Kavas, Cansel Atinkaya Baydemir, Mahmut Gumus
doi: 10.14744/ejmi.2023.42951   Pages  8 -  12 
(Viewed: 483 / Downloaded: 592)

Overcoming Hormone Resistance in Breast Cancer Cell Lines: The Impact of Combined Treatment with Sorafenib and Palbociclib on Cell Survival and Proliferation Pathways
Elvina Almuradova, Erkan Kahraman, Erdem Goker
doi: 10.14744/ejmi.2023.14963   Pages  13 -  20 
(Viewed: 448 / Downloaded: 608)

Fertility Desire and Protection Practices Among Turkish Young Breast Cancer Patients Treated with Chemotherapy
Kubilay Karaboyun, Eyyup Cavdar, Yakup Irıagac, Seher Yildiz Tacar, Okan Avci, Selcuk Seber
doi: 10.14744/ejmi.2023.97379   Pages  21 -  27 
(Viewed: 439 / Downloaded: 585)

Combined LDH Albumin Score (CLAS) and Neutrophil Lymphocyte Ratio (NLR) are Predictive for Survival Patients with Metastatic Non-Small Cell Carcinoma Treated with Nivolumab as Monotherapy
Elif Sahin
doi: 10.14744/ejmi.2023.21564   Pages  28 -  34 
(Viewed: 418 / Downloaded: 571)

Evaluation of Craniovertebral Junction Anatomy by Gender and Age in the Anatolian Population
Asrin Nalbant, Ozden Bedre Duygu, Halide Temelci, Zulal Oner, Serkan Oner
doi: 10.14744/ejmi.2023.47873   Pages  35 -  42 
(Viewed: 467 / Downloaded: 558)

Rechallenge Immunotherapy in Former Interferon-Treated Patients with Metastatic Renal Cell Carcinoma
Elvina Almuradova, Cemre Engin, Rashad Ismayilov
doi: 10.14744/ejmi.2023.11907   Pages  43 -  47 
(Viewed: 456 / Downloaded: 621)

Comparison of the Efficacy of Dual Chemotherapy Regimens in Second-Line Treatment of Metastatic Esophageal Squamous Cell Carcinoma
Gurkan Guner, Yasin Sezgin
doi: 10.14744/ejmi.2023.20180   Pages  48 -  53 
(Viewed: 370 / Downloaded: 591)

Can Pan-Immune Inflammation Value and Systemic Inflammatory Response Index be Used Clinically to Predict Inflammation in Patients with Non-Small Cell Lung Cancer?
Selen Karaoglanoglu, Huseyin Erdal, Muge Karaoglanoglu Sonmez
doi: 10.14744/ejmi.2023.39651   Pages  54 -  57 
(Viewed: 388 / Downloaded: 614)

The Role of Immune-Inflammation Biomarkers to Predict the Response of Nivolumab in Second Line Treatment of Advanced Stage Non-Small Cell Lung Cancer
Ozlem Ozkul, Elif Sahin, Devrim Cabuk, Nadiye Sever, Nargiz Majidova, İbrahim Vedat Bayoglu
doi: 10.14744/ejmi.2023.36214   Pages  58 -  66 
(Viewed: 410 / Downloaded: 614)

Evaluation of PIV Score as a Predictor Biomarker for Pathologically Proven Intermediate-High Risk Gastric Gastrointestinal Stromal Tumors
Oktay Unsal, Ahmet Ozet
doi: 10.14744/ejmi.2023.70078   Pages  67 -  72 
(Viewed: 417 / Downloaded: 592)

Effects of a Multidisciplinary Therapeutic Approach to ''Diabetic Foot'' Complications: A Single-Center Pilot Study from Turkey
Necdet Demir
doi: 10.14744/ejmi.2023.97821   Pages  73 -  78 
(Viewed: 420 / Downloaded: 624)

We have a large number of articles to be published, so newly submitted articles can only be published after December 2022 if it is accepted

Quick Search